Home » Newsletters » BioWorld

BioWorld

Jan. 12, 1993

View Archived Issues

Early Results from Celtrix Wound Trial

PLANT-BASED SELECTABLE MARKER GENE

Isis Researchers Report Findings

H & Q Conference Highlights

GREENWICH FILES NDA FOR THERAFECTIN

LifeCell Warrants Redeemed

EMBREX DEAL WITH POULTRY COMPANY

CHIRON INTRAOPTICS EYES DRUG DELIVERY

POTENTIAL VACCINE PROGRESSES TO PRIMATE

SUGEN-AMGEN DEAL FOR RECEPTOR-BASED DRUGS

TELIOS RESEARCH PACT WITH LILLY

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...